Content about Allergen immunotherapy

May 8, 2013
Merck submits FDA filing for ragweed allergy drug

Drug maker Merck is seeking regulatory approval for an experimental tablet placed under the tongue that could be used to treat ragweed allergies.

August 16, 2012
American College of Allergy, Asthma and Immunology dispels fall allergy myths

According to the American College of Allergy, Asthma and Immunology, 25 million adults and children across the country were diagnosed with rhinitis, or hay fever, within the last 12 months, which may lead many to believe they’ve caught an early-season cold.

July 30, 2012
Eye allergies often ignored

While most people treat nasal allergy symptoms, they often ignore their itchy, red, watery eyes. According to the Asthma and Allergy Foundation of America, approximately 40 million Americans have indoor/outdoor allergies as their primary allergy, and approximately 4% of allergy sufferers have eye allergies as their primary allergy. 


Already with a strong pedigree across eye care and ear care, Similasan recently launched its Kids Irritated Eye Relief for multisymptom relief from redness, burning, stinging and grittiness.

May 16, 2012
High allergy incidence thanks to mild winter

In contrast to the most recent cough-cold season, which was characterized by a relative lack of upper respiratory illnesses, pharmacy shoppers with itchy eyes, runny noses and audible sneezes have been back in force this spring in search of allergy relief.

May 10, 2011
Study: Allergy rhinitis symptoms linked to sleep disruption

Patients with seasonal allergies are more likely to experience difficulty sleeping, according to results of a new survey conducted by Teva Respiratory.

March 22, 2011
Many nasal allergy sufferers don't have control over symptoms

Less than 20% of surveyed patients with nasal allergies find their symptoms are completely controlled over a one-week period of treatment, according to a survey performed by drug maker Teva Pharmaceutical Industries.

© 2013 Drug Store News. All Rights Reserved.